Factors associated w/ poor COVID19 outcomes in #SLE from the GRA @rheum_covid 📌Demographics - age, sex, region 📌Glucocorticoid use 📌 Comorbids - renal, CV 📌Untreated/active dse ❗Very important msg here: Control dse, manage comorbids & avoid GCs @RheumNow #ACR21 abs0866 https://t.co/eXR3KqGrJa

#SLE pts will.... answer in abst#0858 #ACR2021 @RheumNow

Good news for #COVID vaccine in #SLE. ✅doesn’t cause #lupus flares ➡️ no increase in APS. What about #SARS-CoV2 infection in SLE. Flares ↔️ stable but ⬆️APS Abs. from Hopkins cohort. Petri #ACRBest #ACR21 abst0858 @RheumNow https://t.co/ABx4C4lwvs

Dr. Petri noted that 1 week off of immunosuppressants is adequate for most lupus patients to mount a response. She avoided RTX during the pandemic. In pts who have had inadequate response to 2 or 3 doses of mRNA, she switches them to J&J. #ACR21 #COVI19 CH @rheumnow https://t.co/qNjmx9uTLF

HSS Study of 136 SLE flares post-vax: 👉100 (74%) w/expected AE (headache/myalgias) 👉11 (8.1%) pts with SLE flare 👉Majority of flares were mild-mod & occurred w/in 1 week of vaccination 👉Most resolved w/in 7 days. Abst#0896 #ACR21 @rheumnow https://t.co/e6AP8PPRH2

• Systemic Lupus Erythematosus Disease Flares After SARS-CoV-2 Vaccination - ACR …